Total opioid prescriptions annually in the US, enough for 43% of the U.S. population to receive a prescription.
Excess healthcare costs from opioid abuse borne by government and commercial payors and plan sponsors.
Reduction in missing medication from study participants after using LPV.
Reduction in 12-month acute care utilization following MAT program enrollment, generating dramatic savings for insurers and plan sponsors.